Itron
ITRI
207 hedge funds and large institutions have $1.35B invested in Itron in 2014 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 88 increasing their positions, 62 reducing their positions, and 42 closing their positions.
42% more repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 62
11% less funds holding
Funds holding: 232 → 207 (-25)
16% less capital invested
Capital invested by funds: $1.6B → $1.35B (-$254M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
55% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 42
74% less call options, than puts
Call options by funds: $1.46M | Put options by funds: $5.57M
Top Buyers
| 1 |
Harris Associates
Chicago,
Illinois
|
+$33.8M |
| 2 |
FC
Fairpointe Capital
Chicago,
Illinois
|
+$24.7M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$13.1M |
| 4 |
BKBG
BHF Kleinwort Benson Group
Brussels,
Belgium
|
+$9.29M |
| 5 |
OCM
Olstein Capital Management
Purchase,
New York
|
+$8.18M |
Top Sellers
ITRI Hedge Fund Activity: Q1 2014 in Review
207 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Itron (ITRI) for Q1 2014, worth a combined $1.35B — down 16% from $1.6B a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of ITRI and 19 opened new positions — a net loss of 23 holders — while 62 trimmed existing stakes and 88 added.
The largest buyer was Harris Associates, adding an estimated $33.8M. The largest seller was Capital Research Global Investors, cutting an estimated $53M.
- 207 institutional investors held Itron (ITRI) as of Q1 2014, down from 232 in Q4 2013.
- Funds reported $1.35B of Itron stock for Q1 2014, down 16% quarter-over-quarter.
- 19 funds opened new Itron positions in Q1 2014 and 42 closed out, a net change of -23 holders.
- The largest Itron buyer in Q1 2014 was Harris Associates, an estimated $33.8M added.
- The largest Itron seller in Q1 2014 was Capital Research Global Investors, an estimated $53M sold.
Based on aggregated 13F filings for Q1 2014.